U.S. hemophilia treatment market size is expected to reach US$ 6.81 Bn by 2031, from US$ 4.21 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 6.2% during the forecast period. https://www.writerscafe.org/kajalpatil/blogs/U.S.-Hemophilia-Treatment-Market-Set-for-Substantial-Growth-Due-to-Rising-Prevalence-of-Genetic-Bleeding-Disorders-/246084/